Bayer AG completed its $62.5 billion acquisition of seed manufacturer Monsanto Co. on June 7 after receiving all necessary approvals from regulators.
Shareholders of the U.S. agrochemical giant are being paid $128 per share, and its shares will be delisted from the New York Stock Exchange.
J.P. Morgan helped Bayer process the payment of the purchase price for the deal.
Germany-based Bayer said the integration process after the merger is expected to start in about two months. The U.S. Justice Department's conditional approval for the deal stated that the integration can take place as soon as the divestments to German chemical company BASF SE are completed.
"Today's closing represents an important milestone toward the vision of creating a leading agricultural company, supporting growers in their efforts to be more productive and sustainable for the benefit of our planet and consumers," said Hugh Grant, who is stepping down as Monsanto's chairman and CEO.
Liam Condon, a member of Bayer's board of management, will head the combined crop science division after the integration begins, but until then Monsanto will continue to operate independently from Bayer.
